ASSOCIATION BETWEEN COPD SEVERITY AND RETINAL MICROVASCULAR CHANGES: A CROSS-SECTIONAL STUDY
Main Article Content
Keywords
COPD, retinal microvasculature, optical coherence tomography angiography, OCTA, vessel density, hypoxemia, FEV1, GOLD
Abstract
Background Chronic obstructive pulmonary disease (COPD) is associated with systemic inflammation, endothelial dysfunction and chronic hypoxemia, mechanisms that may also affect the retinal microcirculation. Optical coherence tomography angiography (OCTA) provides a non-invasive method for quantifying retinal vascular density. Previous clinical studies have reported lower retinal vessel density in more severe COPD, supporting investigation of the lung–retina relationship.
Aim To assess the association between COPD severity and retinal microvascular parameters measured by OCTA in patients with stable COPD.
Methods A hospital-based cross-sectional observational study was structured according to the collected data. A fixed cohort of 100 adults with spirometry-confirmed COPD was evaluated. Demographic characteristics, smoking exposure, BMI, COPD duration, oxygen saturation, spirometry and OCTA parameters were recorded. Patients were classified into GOLD 1–4 groups according to post-bronchodilator FEV1% predicted. OCTA measurements included superficial capillary plexus (SCP) and deep capillary plexus (DCP) vessel density in the whole image, foveal, parafoveal and perifoveal regions, together with radial peripapillary capillary (RPC) density and foveal avascular zone (FAZ) area.
Results The cohort had a mean age of 64.8 ± 9.1 years and was predominantly male (82%). Mean FEV1 was 48.7 ± 17.2% predicted. Retinal microvascular density progressively decreased with increasing COPD severity. Mean foveal SCP density was 22.8 ± 5.1% in GOLD 1, 21.5 ± 5.0% in GOLD 2, 19.0 ± 4.7% in GOLD 3 and 16.4 ± 4.5% in GOLD 4. Mean foveal DCP density was 39.1 ± 6.5%, 37.0 ± 6.2%, 33.1 ± 6.0% and 29.2 ± 5.6%, respectively. The differences were statistically significant. FEV1% predicted and resting SpO₂ showed positive correlations with foveal and parafoveal vessel density, whereas mMRC score and smoking exposure showed inverse correlations.
Conclusion Greater COPD severity was associated with lower retinal microvascular density in this cohort. OCTA may provide a non-invasive window into systemic microvascular alterations associated with COPD.
References
2.Agustí A, Celli BR, Criner GJ, et al. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Eur Respir J. 2016;61(4):2300239.
3.Soğut S, et al. Evaluation of retinal microvasculature according to stable chronic obstructive pulmonary disease severity and the correlation of pulmonary parameters with optical coherence tomography angiography findings. [Study indexed in PubMed PMID: 35502048].
4.Kocak N, et al. The alterations of retinal vasculature detected on optical coherence tomography angiography associated with chronic obstructive pulmonary disease. [Study indexed in PubMed PMID: 35146915].
5.Ozturk M, et al. Retinal Vascular Changes in Patients with Chronic Obstructive Pulmonary Disease: An Optical Coherence Tomography Angiography Study. [Study indexed in PubMed PMID: 34349598].
6.McKay GJ, et al. Simple non-mydriatic retinal photography is feasible and demonstrates retinal microvascular dilation in Chronic Obstructive Pulmonary Disease (COPD). [Study indexed in PubMed PMID: 31923188].
7.Investigation of ocular microstructural changes according to disease severity in patients with chronic obstructive pulmonary disease. [Study indexed in PubMed PMID: 36306881].
8.The evaluation of retinal and choroidal structural changes by optical coherence tomography in patients with chronic obstructive pulmonary disease. [Study indexed in PubMed PMID: 28956644].
9.Alterations of retinal microvascular density in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis. Prog Med? Drug Discov? 2014; DOI:10.1016/j.pdpdt.2022.104690.
10.Skin autofluorescence as a measure of advanced glycation end-products is associated with microvascular health in patients with COPD. [Indexed in PubMed PMID: 32763256].
11.Graham BL, Steenbruggen I, Miller MR, et al. Standardization of Spirometry 2019 Update. Am J Respir Crit Care Med. 2019;200(8):e70-e88.
12.Stanojevic S, Kaminsky DA, Miller MR, et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J. 2022;60(1):2101499.
13.Hogg JC, Timens W. The pathology of chronic obstructive pulmonary disease. Annu Rev Pathol. 2009;4:435-459.
14.Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370(9589):765-773.
15.Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J. 1977;1(6077):1645-1648. doi:10.1136/bmj.1.6077.1645.

